| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 689176 | Null | 0.0102962192514438 | 0.22080852 |
| NSC 700203 | Null | 0.0102962192514438 | 0.49218344 |
| NSC 704886 | 2-Butenedioic acid, 2-[5-chloro-2,4-dioxo-3-(2-propynyl)-1H,3H-pyrimidinyl]-,diethyl ester, (2E)- | 0.0102962192514438 | 0.55554552 |
| NSC 705928 | Null | 0.0102962192514438 | 0.54156589 |
| NSC 710373 | Null | 0.0102962192514438 | 0.36354339 |
| NSC 71097 | Null | 0.0102962192514438 | 0.6657731 |
| NSC 711806 | Null | 0.0102962192514438 | 0.26564072 |
| NSC 744331 | (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd | 0.0102962192514439 | 0.54318309 |
| NSC 208652 | 2,4-Quinazolinediamine, 5-chloro-6-[[(3,4-dichlorophenyl)amino]methyl]- | 0.0107933723273943 | 0.21569448 |
| NSC 225112 | 2,4,6-Quinazolinetriamine, N(6)-[(3,4-dichlorophenyl)methyl]-N(6)-ethyl-5-methyl- | 0.0107933723273943 | 0.18179377 |